Insufficient nitric oxide bioavailability: A hypothesis to explain adverse effects of red blood cell transfusion

Transfusion

Volumn 51, Issue 4, 2011, Pages 859-866

  Roback, John D ^a   Neuman, Robert B ^a   Quyyumi, Arshed ^a   Sutliff, Roy ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN; NITRIC OXIDE;

ANEMIA; BIOAVAILABILITY; BLOOD STORAGE; BLOOD VESSEL TONE; CONFERENCE PAPER; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE TRANSFUSION; HUMAN; INFLAMMATION; MORBIDITY; MORTALITY; OXIDATIVE STRESS; STEM CELL; VASOCONSTRICTION;

BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; NITRIC OXIDE;

EID: 79954614825     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03094.x     Document Type: Conference Paper

References (60)

1. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH,. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358: 1229-39. (Pubitemid 351439224)
2. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E,. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17. (Pubitemid 29084771)
3. Health Care Cost and Utilization Project (HCUP). Facts and figures, 2007. Exhibit 3.1. Most frequent all-listed procedures. [cited 2011 Feb 15]. Available from: URL
4. Hillyer CD, Blumberg N, Glynn SA, Ness PM,; NHLBI Working Group in Transfusion Recipient Epidemiology and Outcomes Research. Transfusion recipient epidemiology and outcomes research: possibilities for the future. Transfusion 2008; 48: 1530-7.
5. Klein HG, Lipton KS,. Association Bulletin #01-4: non-infectious serious hazards of transfusion. Bethesda (MD): American Association of Blood Banks; 2001. [cited 2011 Feb 15]. Available from: URL
6. Dodd RY, Notari EP, Stramer SL,. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population [comment]. Transfusion 2002; 42: 975-9.
7. Corash L,. Pathogen reduction technology: methods, status of clinical trials, and future prospects. Curr Hematol Rep 2003; 2: 495-502.
8. Kleinman S,. A perspective on transfusion-related acute lung injury two years after the Canadian Consensus Conference. Transfusion 2006; 46: 1465-8. (Pubitemid 44326317)
9. Kuehnert MJ, Roth VR, Haley NR, Gregory KR, Elder KV, Schreiber GB, Arduino MJ, Holt SC, Carson LA, Banerjee SN, Jarvis WR,. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 2001; 41: 1493-9. (Pubitemid 34072672)
10. Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ,. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007; 47: 1134-42. (Pubitemid 46934307)
11. Tobian AA, Sokoll LJ, Tisch DJ, Ness PM, Shan H,. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008; 48: 1143-50. (Pubitemid 351793483)
12. Josephson CD, Su LL, Hillyer KL, Hillyer CD,. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev 2007; 21: 118-33. (Pubitemid 46482993)
13. Blajchman MA,. Transfusion-associated immunomodulation and universal white cell reduction: are we putting the cart before the horse? Transfusion 1999; 39: 665-70. (Pubitemid 29328476)
14. Tinmouth A, Fergusson D, Yee IC, Hebert PC,. Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46: 2014-27. (Pubitemid 44631611)
15. van de Watering L, Lorinser J, Versteegh M, Westendord R, Brand A,. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion 2006; 46: 1712-8. (Pubitemid 44435723)
16. Mou SS, Giroir BP, Molitor-Kirsch EA, Leonard SR, Nikaidoh H, Nizzi F, Town DA, Roy LC, Scott W, Stromberg D,. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants. N Engl J Med 2004; 351: 1635-44. (Pubitemid 39350424)
17. Weiskopf RB, Feiner J, Hopf H, Lieberman J, Finlay HE, Quah C, Kramer JH, Bostrom A, Toy P,. Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans. Anesthesiology 2006; 104: 911-20.
18. Garcia MG, Duenas E, Sola MC, Hutson AD, Theriaque D, Christensen RD,. Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 2001; 21: 415-20. (Pubitemid 32976172)
19. Del Vecchio A, Sola MC, Theriaque DW, Hutson AD, Kao KJ, Wright D, Garcia MG, Pollock BH, Christensen RD,. Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions. Transfusion 2001; 41: 803-8. (Pubitemid 32538518)
20. Moore FA, Moore EE, Sauaia A,. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997; 132: 620-4. Discussion 624-5.
21. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC,. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005; 33: 1191-8. (Pubitemid 40827364)
22. Smith MJ, Roux PDL, Elliott JP, Winn HR,. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 2004; 101: 1-7. (Pubitemid 38808453)
23. Lacroix J, Hebert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, Gauvin F, Collet JP, Toledano BJ, Robillard P, Joffe A, Biarent D, Meert K, Peters MJ,. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356: 1609-19. (Pubitemid 46631670)
24. Kneyber MC, Hersi MI, Twisk JW, Markhorst DG, Plotz FB,. Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med 2007; 33: 1414-22. (Pubitemid 47101723)
25. Reynolds JD, Ahearn GS, Angelo M, Zhang J, Cobb F, Stamler JS,. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A 2007; 104: 17058-62. (Pubitemid 350210991)
26. Bennett-Guerrero E, Veldman TH, Doctor A, Telen MJ, Ortel TL, Reid TS, Mulherin MA, Zhu H, Buck RD, Califf RM, McMahon TJ,. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 2007; 104: 17063-8. (Pubitemid 350210992)
27. Ghio M, Contini P, Mazzei C, Brenci S, Barberis G, Filaci G, Indiveri F, Puppo F,. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 1999; 93: 1770-7. (Pubitemid 29102506)
28. Corwin HL, Carson JL,. Blood transfusiona′when is more really less? N Engl J Med 2007; 356: 1667-9. (Pubitemid 46631678)
29. Spiess BD,. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth 2004; 8: 267-81. (Pubitemid 39603175)
30. Singel DJ, Stamler JS,. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol 2005; 67: 99-145. (Pubitemid 40404487)
31. Suematsu M, Suganuma K, Kashiwagi S,. Mechanistic probing of gaseous signal transduction in microcirculation. Antioxid Redox Signal 2003; 5: 485-92. (Pubitemid 37087409)
32. Villar IC, Francis S, Webb A, Hobbs AJ, Ahluwalia A,. Novel aspects of endothelium-dependent regulation of vascular tone. Kidney Int 2006; 70: 840-53. (Pubitemid 44285961)
33. Walford G, Loscalzo J,. Nitric oxide in vascular biology. J Thromb Haemost 2003; 1: 2112-8.
34. Feletou M, Vanhoutte PM,. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 2006; 26: 1215-25. (Pubitemid 44305364)
35. Bryan RM, Jr JY, Golding EM, Marrelli SP,. Endothelium-derived hyperpolarizing factor: a cousin to nitric oxide and prostacyclin. Anesthesiology 2005; 102: 1261-77. (Pubitemid 40745846)
36. Chen K, Piknova B, Pittman RN, Schechter AN, Popel AS,. Nitric oxide from nitrite reduction by hemoglobin in the plasma and erythrocytes. Nitric Oxide 2008; 18: 47-60. (Pubitemid 350299198)
37. Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang JD Jr, Kraus D, Ho C, Gladwin MT, Patel RP,. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 2006; 107: 566-74. (Pubitemid 43076380)
38. Allen BW, Piantadosi CA,. How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm. Am J Physiol Heart Circ Physiol 2006; 291: H1507-12. (Pubitemid 44497652)
39. Dzik S,. Nitric oxide: nature's third respiratory gas. Transfusion 2002; 42: 1532-3.
40. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ, Gruetter CA,. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981; 218: 739-49. (Pubitemid 11005147)
41. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J,. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A 1992; 89: 444-8.
42. Pawloski JR, Stamler JS,. Nitric oxide in RBCs. Transfusion 2002; 42: 1603-9.
43. Winslow RM, Intaglietta M,. Red cell age and loss of function: advance or SNO-job? Transfusion 2008; 48: 411-4. (Pubitemid 351294594)
44. Lundberg JO, Weitzberg E, Gladwin MT,. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008; 7: 156-67. (Pubitemid 351194063)
45. Chen K, Popel AS,. Theoretical analysis of biochemical pathways of nitric oxide release from vascular endothelial cells. Free Radic Biol Med 2006; 41: 668-80. (Pubitemid 44102718)
46. Chen K, Pittman RN, Popel AS,. Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal 2008; 10: 1185-98. (Pubitemid 351620307)
47. Lancaster J, Hutchings A, Kerby JD, Patel RP,. The hemoglobin-nitric oxide axis: implications for transfusion therapeutics. Transfus Alternat Transfus Med 2007; 9: 273-80.
48. Feletou M, Vanhoutte PM,. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006; 291: H985-1002. (Pubitemid 44343640)
49. Quyyumi AA,. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998; 105: 32S-9S. (Pubitemid 28364424)
50. Cai H, Harrison DG,. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840-4.
51. Dzau VJ,. Theodore Cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001; 37: 1047-52. (Pubitemid 32304002)
52. Papaharalambus CA, Griendling KK,. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 2007; 17: 48-54. (Pubitemid 46205327)
53. McDermott DH, Halcox JP, Schenke WH, Waclawiw MA, Merrell MN, Epstein N, Quyyumi AA, Murphy PM,. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 2001; 89: 401-7. (Pubitemid 34132655)
54. Zhu J, Quyyumi AA, Rott D, Csako G, Wu H, Halcox J, Epstein SE,. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001; 103: 1071-5. (Pubitemid 32200179)
55. Zhu J, Quyyumi AA, Wu H, Csako G, Rott D, Zalles-Ganley A, Ogunmakinwa J, Halcox J, Epstein SE,. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2003; 23: 1055-9. (Pubitemid 36713560)
56. Chait A, Han CY, Oram JF, Heinecke JW,. Thematic review series: the immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J Lipid Res 2005; 46: 389-403.
57. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR,. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-65. (Pubitemid 35315836)
58. Zalewski A, Macphee C,. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol 2005; 25: 923-31. (Pubitemid 40627835)
59. Garza CA, Montori VM, McConnell JP, Somers VK, Kullo IJ, Lopez-Jimenez F,. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc 2007; 82: 159-65. (Pubitemid 46198473)
60. Seppa N,. Bad blood? Old units might be substandard. Sci News 2008; 173: 179.